This inventor holds 2 USPTO granted patents and 1 published patent application. Top assignees: Case Western Reserve University, The University of Texas System. Active years: 2022-2023.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:


Years Active: 2022-2023
Title: The Innovations of Yiyuan Yuan
Introduction
Yiyuan Yuan is a notable inventor based in Cleveland, OH, who has made significant contributions to the field of medical science. With a total of two patents to his name, Yuan's work focuses on innovative methods for modulating key biological processes.
Latest Patents
Yuan's latest patents include compositions and methods of modulating short-chain dehydrogenase. This patent addresses compounds and methods for modulating 15-PGDH activity, which is crucial for regulating tissue prostaglandin levels. The invention aims to treat various diseases and conditions where modulation of 15-PGDH activity and prostaglandin levels is desired. Another significant patent involves inhibitors of short-chain dehydrogenase activity for treating coronary disorders. This method outlines a therapeutic approach for preventing and reversing congestive heart failure and cardiomyopathy by administering a therapeutically effective amount of a 15-PGDH inhibitor.
Career Highlights
Yiyuan Yuan has had a distinguished career, working with prestigious institutions such as Case Western Reserve University and the University of Texas System. His research has contributed to advancements in understanding and treating cardiovascular diseases.
Collaborations
Yuan has collaborated with esteemed colleagues, including Sanford D. Markowitz and Joseph Ready, enhancing the impact of his research through shared expertise and knowledge.
Conclusion
Yiyuan Yuan's innovative patents and collaborations highlight his commitment to advancing medical science, particularly in the treatment of coronary disorders. His work continues to influence the field and offers hope for improved therapeutic strategies.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile